Showing results (31-40 of 596) with videos related to
Sort By:
Pageof 60
The American Journal of Psychiatry|August 12, 1998
Individual differences in cognitive decline in schizophreniaG Goldstein, D N Allen, D P van KammenPsychiatry Research|April 1, 1982
Cerebrospinal fluid hydroxylase cofactor in schizophreniaJ C Garbutt, D P van Kammen, R A Levine, et al.The Psychiatric Clinics of North America|March 1, 1986
Cerebrospinal fluid studies of monoamine metabolism in schizophreniaD P van Kammen, J Peters, W B van KammenBiological Psychiatry|June 5, 1999
Human plasma glutathione peroxidase and symptom severity in schizophreniaJ K Yao, R D Reddy, D P van KammenCNS Drugs|July 21, 2001
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implicationsJ K Yao, R D Reddy, D P van KammenSchizophrenia Research|October 1, 1994
Red blood cell membrane dynamics in schizophrenia. II. Fatty acid compositionJ K Yao, D P van Kammen, J A WelkerThe Journal of Nursing Administration|September 1, 1992
Recognizing excellence. Giving your AWED Webb, C Tour, R Hurt, et al.The American Journal of Psychiatry|May 1, 1979
Reduced cyclic AMP production in the blood platelets from schizophrenic patientsM S Kafka, D P van Kammen, W E BunneyPsychiatry Research|February 28, 1996
Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophreniaJ K Yao, D P van Kammen, J A GurklisThe British Journal of Psychiatry : the Journal of Mental Science|August 1, 1978
Serum calcium and magnesium in schizophrenia: relationship to clinical phenomena and neuroleptic treatmentP E Alexander, D P Van Kammen, W E BunneyPageof 60